Dubash, S., et al.. Personalising Care: Using Infliximab Drug Trough and Anti-drug Antibody Levels Improves Clinical Treatment Decisions and Is a Cost-effective Strategy in Spondyloarthritis. no. Suppl 2, Royal College of Physicians, 2019, doi:10.7861/clinmedicine.19-2-s106.